EGFR, p16, HPV Titer, Bcl-xL and p53, Sex, and Smoking As Indicators of Response to Therapy and Survival in Oropharyngeal Cancer
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Purpose: To prospectively identify markers of response to therapy and outcome in an organ-sparing trial for advanced oropharyngeal cancer. Patients and Methods: Pretreatment biopsies were examined for expression of epidermal growth factor receptor (EGFR), p16, Bcl-xL, and p53 as well as for p53 mutation. These markers were assessed for association with high-risk human papillomavirus (HPV), response to therapy, and survival. Patient variables included smoking history, sex, age, primary site, tumor stage, and nodal status. Results: EGFR expression was inversely associated with response to induction chemotherapy (IC) (P = .01), chemotherapy/radiotherapy (CRT; P = .055), overall survival (OS; P = .001), and disease-specific survival (DSS; P = .002) and was directly associated with current smoking (P = .04), female sex (P = .053), and lower HPV titer (P = .03). HPV titer was significantly associated with p16 expression (P < .0001); p16 was significantly associated with response to IC (P = .008), CRT (P = .009), OS (P = .001), and DSS (P = .003). As combined markers, lower HPV titer and high EGFR expression were associated with worse OS (ρ EGFR = 0.008; ρ HPV = 0.03) and DSS (ρ EGFR = 0.01; ρ HPV = 0.016). In 36 of 42 biopsies, p53 was wild-type, and only one HPV-positive tumor had mutant p53. The combination of low p53 and high Bcl-xL expression was associated with poor OS (P = .005) and DSS (P = .002). Conclusion: Low EGFR and high p16 (or higher HPV titer) expression are markers of good response to organ-sparing therapy and outcome, whereas high EGFR expression, combined low p53/high Bcl-xL expression, female sex, and smoking are associated with a poor outcome. Smoking cessation and strategies to target EGFR and Bcl-xL are important adjuncts to the treatment of oropharyngeal cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Bcl-2 Protein Family: Arbiters of Cell Survival
Adams, J. M., & Cory, S. (1998) · Science · doi:10.1126/science.281.5381.1322 · Cited by 5,332
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
ERBB receptors and cancer: the complexity of targeted inhibitors
Hynes, N. E., & Lane, H. A. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1609 · Cited by 3,313
Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers
Gillison, M. L. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.9.709 · Cited by 3,101
(1991) · New England Journal of Medicine · doi:10.1056/nejm199106133242402 · Cited by 2,733
Epidermal Growth Factor Receptor Biology in Head and Neck Cancer
Kalyankrishna, S., & Grandis, J. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.8306 · Cited by 747
Clinical Implications of Human Papillomavirus in Head and Neck Cancers
Fakhry, C., & Gillison, M. L. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.1291 · Cited by 499
Klussmann, J. P., Gültekin, E., Weissenborn, S. J., Wieland, U., Dries, V., Dienes, H. P., Eckel, H. E., Pfister, H. J., & Fuchs, P. G. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63871-0 · Cited by 431
Reed, J. C., Miyashita, T., Takayama, S., Wang, H.-G., Sato, T., Krajewski, S., Aimé-Sempé, C., Bodrug, S., Kitada, S., & Hanada, M. (1996) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19960101)60:1<23::aid-jcb5>3.0.co;2-5 · Cited by 422
Combined analysis of HPV‐DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer
Reimers, N., Kasper, H. U., Weissenborn, S. J., Stützer, H., Preuss, S. F., Hoffmann, T. K., Speel, E. J. M., Dienes, H. P., Pfister, H. J., Guntinas‐Lichius, O., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22355 · Cited by 420
Cited by
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
Ang, K. K., Harris, J., Wheeler, R., Weber, R., Rosenthal, D. I., Nguyen-Tân, P. F., Westra, W. H., Chung, C. H., Jordan, R. C., Lu, C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0912217 · Cited by 6,566
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
Chaturvedi, A. K., Engels, E. A., Pfeiffer, R. M., Hernandez, B. Y., Xiao, W., Kim, E., Jiang, B., Goodman, M. T., Sibug-Saber, M., Cozen, W., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.4596 · Cited by 3,638
HPV-associated head and neck cancer: a virus-related cancer epidemic
Marur, S., D'Souza, G., Westra, W. H., & Forastiere, A. A. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70017-6 · Cited by 1,816
Bmi1 is essential in Twist1-induced epithelial–mesenchymal transition
Yang, M.-H., Hsu, D. S.-S., Wang, H.-W., Wang, H.-J., Lan, H.-Y., Yang, W.-H., Huang, C.-H., Kao, S.-Y., Tzeng, C.-H., Tai, S.-K., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2099 · Cited by 631
Lassen, P., Eriksen, J. G., Hamilton-Dutoit, S., Tramm, T., Alsner, J., & Overgaard, J. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.2853 · Cited by 612
Dayyani, F., Etzel, C. J., Liu, M., Ho, C.-H., Lippman, S. M., & Tsao, A. S. (2010) · Head & Neck Oncology · doi:10.1186/1758-3284-2-15 · Cited by 529
Epidemiology of Head and Neck Cancer
Rettig, E. M., & D’Souza, G. (2015) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2015.03.001 · Cited by 524
STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients
Vasquez-Dunddel, D., Pan, F., Zeng, Q., Gorbounov, M., Albesiano, E., Fu, J., Blosser, R. L., Tam, A. J., Bruno, T., Zhang, H., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci60083 · Cited by 507
Gillison, M. L., Zhang, Q., Jordan, R., Xiao, W., Westra, W. H., Trotti, A., Spencer, S., Harris, J., Chung, C. H., & Ang, K. K. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.4099 · Cited by 487
Vermorken, J. B., Stöhlmacher-Williams, J., Davidenko, I., Licitra, L., Winquist, E., Villanueva, C., Foa, P., Rottey, S., Skladowski, K., Tahara, M., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70181-5 · Cited by 440
Human Papillomavirus in Head and Neck Cancer: Its Role in Pathogenesis and Clinical Implications
Chung, C. H., & Gillison, M. L. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0784 · Cited by 418
Zhong, L.-P., Zhang, C.-P., Ren, G.-X., Guo, W., William, W. N., Sun, J., Zhu, H.-G., Tu, W.-Y., Li, J., Cai, Y.-L., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.8820 · Cited by 394
Self-citationTumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer
Ward, M. J., Thirdborough, S. M., Mellows, T., Riley, C., Harris, S., Suchak, K., Webb, A., Hampton, C., Patel, N. N., Randall, C. J., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.639 · Cited by 391
Beyond Cervical Cancer: Burden of Other HPV-Related Cancers Among Men and Women
Chaturvedi, A. K. (2010) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2010.01.016 · Cited by 361
Worden, F. P., Kumar, B., Lee, J. S., Wolf, G. T., Cordell, K. G., Taylor, J. M. G., Urba, S. G., Eisbruch, A., Teknos, T. N., Chepeha, D. B., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.7597 · Cited by 357
Self-citationTumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma
Nguyen, N., Bellile, E., Thomas, D., McHugh, J., Rozek, L., Virani, S., Peterson, L., Carey, T. E., Walline, H., Moyer, J., et al. (2016) · Head & Neck · doi:10.1002/hed.24406 · Cited by 353
Self-citationRieckmann, T., Tribius, S., Grob, T. J., Meyer, F., Busch, C.-J., Petersen, C., Dikomey, E., & Kriegs, M. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.03.013 · Cited by 312
Emerging biomarkers in head and neck cancer in the era of genomics
Kang, H., Kiess, A., & Chung, C. H. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.192 · Cited by 310
Maxwell, J. H., Kumar, B., Feng, F. Y., Worden, F. P., Lee, J. S., Eisbruch, A., Wolf, G. T., Prince, M. E., Moyer, J. S., Teknos, T. N., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2350 · Cited by 306
Self-citationMasterson, L., Moualed, D., Liu, Z. W., Howard, J. E. F., Dwivedi, R. C., Tysome, J. R., Benson, R., Sterling, J. C., Sudhoff, H., Jani, P., et al. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.07.001 · Cited by 288
Head and neck cancer prevention: from primary prevention to impact of clinicians on reducing burden
Hashim, D., Genden, E., Posner, M., Hashibe, M., & Boffetta, P. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz084 · Cited by 265
Ang, K. K., & Sturgis, E. M. (2012) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2011.12.004 · Cited by 260
Kies, M. S., Holsinger, F. C., Lee, J. J., William, W. N., Glisson, B. S., Lin, H. Y., Lewin, J. S., Ginsberg, L. E., Gillaspy, K. A., Massarelli, E., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.0425 · Cited by 253
Self-citationVariable expression of the forgotten oncogene E5 in HPV-positive oropharyngeal cancer
Um, S. H., Mundi, N., Yoo, J., Palma, D. A., Fung, K., MacNeil, D., Wehrli, B., Mymryk, J. S., Barrett, J. W., & Nichols, A. C. (2014) · Journal of Clinical Virology · doi:10.1016/j.jcv.2014.06.019 · Cited by 31
The Use of HPV16-E5, EGFR, and pEGFR as Prognostic Biomarkers for Oropharyngeal Cancer Patients
Taberna, M., Torres, M., Alejo, M., Mena, M., Tous, S., Marquez, S., Pavón, M. A., León, X., García, J., Guix, M., et al. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00589 · Cited by 26
Metadata
- Authors
- Kumar, B., Cordell, K. G., Lee, J. S., Worden, F. P., Prince, M. E., Tran, H. H., Wolf, G. T., Urba, S. G., Chepeha, D. B., Teknos, T. N., Eisbruch, A., Tsien, C. I., Taylor, J. M. G., D’Silva, N. J., Yang, K., Kurnit, D. M., Bauer, J. A., Bradford, C. R., & Carey, T. E.
- Venue
- Journal of Clinical Oncology
- Published
- 2008-07-01
- Volume
- 26
- Issue
- 19
- Pages
- 3128-3137
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2117781588
- Cited by
- 612
- References
- 38
- FWCI
- 45.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.